Market Entry Target small medical equipment buyers and consumer health tech retailers seeking affordable neuropsychiatric solutions. The Fisher Wallace Stimulator is FDA-cleared, cost-conscious, and positioned for broad accessibility, suggesting partnership potential with clinics, telehealth platforms, and direct-to-consumer channels looking to expand mental health offerings.

Strategic Partnerships Leverage the collaboration pedigree with Beats and Nest to pursue co-branding or white-label opportunities with wellness platforms, corporate wellness programs, and sleep therapy services that emphasize neuroscience-backed devices.

Funding Momentum Capitalize on recent equity crowdfunding activity and notable investor interest to engage growth-stage funds, accelerators, and strategic investors for distribution expansions, R&D collaborations, or international market entry.

Compliance and Access Focus on healthcare distributors and insurance reimbursement teams by highlighting FDA-approved status, price point, and scalability. Develop value propositions around reducing clinician time and offering at-home treatment options to expand payer acceptance.

Tech and Data Promote the existing tech stack and data capabilities to partners in digital health ecosystems. Offer integration with patient management, e-commerce, and analytics platforms to enable outcome tracking, personalized therapy recommendations, and enhanced marketing reach.